Cardiac tamponade as an unusual initial presentation of squamous cell carcinoma of the esophagus

Pericardial effusions leading to cardiac tamponade have previously been described with esophageal cancer. However, up to eighty percent of these cases have been reported in association with chemotherapy and radiation. Patients with esophageal cancer seldom initially present with pericardial effusion resulting from esophageal pericardial fistula (EPF). Herein, we present the case of a 62-year-old man who presented with pericardial effusion with an unknown etiology at presentation. Subsequently, the patient developed cardiac tamponade and was referred to the tertiary hospital for further evaluation. Computed tomography of the chest revealed a circumferential irregular enhancing lesion at the mid-thoracic esophagus suspecting esophageal cancer with EPF and a moderate amount of pericardial effusion. The patient underwent esophagoscopy and squamous cell carcinoma was found from the esophageal biopsy. An esophageal stent was successfully placed to conceal the perforation. Eventually, the patient died 13 days after admission complicated by refractory septic shock. This case highlights an atypical presentation of esophageal cancer and an unusual cause of cardiac tamponade.

Cardiac tamponade; Esophageal cancer; Pericardial effusion; Esophagus; Esophageal pericardial fistula

[1] Adler Y, Charron P. The 2015 ESC Guidelines for the diagnosis and management of pericardial diseases. European Heart Journal. 2015; 36: 2873–2874.

[2] Abdullah HMA, Khan UI, Wasekar C, Omar M. Cardiac tamponade and purulent pericarditis secondary to an oesophageal pericardial fistula as an initial presentation of squamous cell carcinoma of the oesophagus. BMJ Case Reports. 2019; 12: e229634.

[3] Saluja SS, Puri SK, Arora A, Chander Sharma B, Mishra PK. Esophagopericardial fistula: a delayed complication after esophageal stenting. the American Surgeon. 2013; 79: 550–552.

[4] Touati GD, Carmi D, Nzomvuama A, Marticho P. Purulent pericarditis caused by malignant oesophago-pericardial fistula. European Journal of Cardio-Thoracic Surgery. 2003; 24: 847–849.

[5] Kaufman J, Thongsuwan N, Stern E, Karmy-Jones R. Esophageal-pericardial fistula with purulent pericarditis secondary to esophageal carcinoma presenting with tamponade. The Annals of Thoracic Surgery. 2003; 75: 288–289.

[6] Tombazzi C, Marino G, Yong J, Vallejo V, Reddy K. Malignant esophageal pericardial fistula presenting as cardiac tamponade. Digestive Diseases and Sciences. 2006; 51: 1290–1293.

[7] Kariyanna PT, Jayarangaiah A, Pedalino R, Hegde S, Marmur JD, Shenoy A, et al. Esophago-pericardial Fistula Induced Community Acquired Methicillin Resistant Staphylococcus Aureus (CA-MRSA) Cardiac Tamponade—a Rare Case Report and Literature Review. American Journal of Medical Case Reports. 2018; 6: 109–113.

[8] Wang M-C, Huang B-H, Kok VC. Esophagopericardial fistula and purulent pericarditis causing cardiac tamponade during concurrent chemoradiotherapy for esophageal cancer: A case report. Therapeutic Radiology and Oncology. 2017; 24: 67–75.

[9] Chen R, Zheng RS, Zhang SW, Zeng HM, Wang SM, Sun KX, et al. Analysis of incidence and mortality of esophageal cancer in China, 2015. Zhonghua Yu Fang Yi Xue Za Zhi. 2019; 53: 1094–1097. (In Chinese)

[10] Zarean E, Mahmoudi M, Azimi T, Amini P. Determining Overall Survival and Risk Factors in Esophageal Cancer Using Censored Quantile Regression. Asian Pacific Journal of Cancer Prevention. 2018; 19: 3081–3086.